quantisnow
FeedTopReportsPricing
⌘K
Live feed
18:34:08·1154d
INSIDERFiling
CinCor Pharma Inc. logo

SEC Form 4: De Garidel Marc returned 200,000 shares to the company, closing all direct ownership in the company to cover taxes

CINC· CinCor Pharma Inc.
Health Care
Original source

Companies

  • CINC
    CinCor Pharma Inc.
    Health Care

Recent analyst ratings

  • Dec 7UpdateBarclays$22.00
  • Nov 29UpdateOppenheimer-
  • Nov 29UpdateMorgan Stanley$22.00
  • Oct 28UpdateGoldman$67.00
  • Aug 22UpdatePiper Sandler$73.00
  • Feb 1UpdateEvercore ISI-

Related

  • PR540d
    Axonis Therapeutics Announces $115 Million Series A Financing
  • PR630d
    venBio Raises $528 Million Venture Capital Fund Focused on Life Science Companies
  • PR1077d
    Impel Pharmaceuticals Announces First Quarter 2023 Financial Results and Provides Business Update
  • PR1127d
    5AM Ventures Celebrates 20th FDA Product Approval Investing in Breakthrough Science
  • 13D/G1147d
    SEC Form SC 13D/A filed by CinCor Pharma Inc. (Amendment)
  • 13D/G1149d
    SEC Form SC 13D/A filed by CinCor Pharma Inc. (Amendment)
  • 13D/G1150d
    SEC Form SC 13D/A filed by CinCor Pharma Inc. (Amendment)
  • INSIDER1150d
    SEC Form 4 filed by 5am Partners Vi, Llc
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022